| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.3B | $13.8B | $14.8B | $17.0B | $14.1B | $8.8B | $11.0B | $2.8B |
| Cost of Revenue | — | — | — | — | — | — | — | $2.1B |
| Gross Profit | — | — | — | — | — | $0.7B | $0.8B | $0.7B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.8B | $2.7B | $2.6B | $2.5B | $2.3B | $1.9B | $2.1B | $2.1B |
| Operating Income | $1.0B | $1.2B | $1.7B | $2.5B | $1.9B | $0.6B | $1.0B | $0.9B |
| Net Income | $0.7B | $0.9B | $1.3B | $1.8B | $1.4B | $0.1B | $0.2B | $0.1B |
| EPS (Basic) | $14.07 | $15.70 | $22.90 | $30.39 | $22.35 | $2.04 | $2.48 | $1.23 |
| EPS (Diluted) | $13.98 | $15.56 | $22.64 | $29.92 | $21.97 | $2.01 | $2.44 | $1.22 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.4B | $10.0B | $10.5B | $10.3B | $9.5B | $8.1B | $8.1B | $8.0B |
| Current Assets | $4.1B | $3.9B | $4.8B | $4.9B | $4.2B | $3.1B | $3.0B | $3.3B |
| Cash & Equivalents | $0.2B | $0.3B | $1.1B | $1.2B | $0.3B | $0.7B | $0.2B | $0.1B |
| Total Liabilities | $3.2B | $2.8B | $2.7B | — | — | — | — | — |
| Current Liabilities | $0.8B | $1.2B | $0.8B | $1.4B | $1.1B | $0.6B | $0.7B | $0.7B |
| Stockholders' Equity | $7.2B | $7.2B | $7.7B | $7.1B | $6.1B | $5.1B | $5.2B | $4.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $1.4B | $1.7B | $2.1B | $0.8B | $1.2B | $1.3B | $0.7B |
| Investing Cash Flow | $-0.3B | $-0.8B | $-0.5B | $-0.3B | $-0.7B | $-0.2B | $-0.4B | $-0.3B |
| Capital Expenditures | $0.3B | $0.4B | $0.5B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $-0.6B | $-1.4B | $-1.3B | $-0.9B | $-0.5B | $-0.5B | $-0.8B | $-0.4B |